SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-001446
Filing Date
2021-08-13
Accepted
2021-08-13 16:58:50
Documents
56
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ziop-20210630.htm   iXBRL 10-Q 2002948
2 EX-31.1 ziop-20210630ex31_1.htm EX-31.1 12116
3 EX-31.2 ziop-20210630ex31_2.htm EX-31.2 12272
4 EX-32.1 ziop-20210630ex32_1.htm EX-32.1 9825
  Complete submission text file 0000950170-21-001446.txt   6680869

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ziop-20210630_lab.xml EX-101.LAB 417496
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ziop-20210630.xsd EX-101.SCH 50981
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ziop-20210630_def.xml EX-101.DEF 266508
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ziop-20210630_cal.xml EX-101.CAL 22303
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ziop-20210630_pre.xml EX-101.PRE 339835
10 EXTRACTED XBRL INSTANCE DOCUMENT ziop-20210630_htm.xml XML 967526
Mailing Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129
Business Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129 617-259-1970
ZIOPHARM ONCOLOGY INC (Filer) CIK: 0001107421 (see all company filings)

IRS No.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33038 | Film No.: 211173138
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences